Search research articles
Contact Us
Filters
Showing results (271-280 of 470) with videos related to
Page
of 47
Sort By:
The Cochrane Database of Systematic Reviews
|
July 14, 2021
Mini-Cog for the detection of dementia within a community setting
Bruce A Fage, Calvin Ch Chan, Sudeep S Gill, et al.
Psychiatry Research
|
July 6, 2019
Symptoms of depression and cognitive impairment in young adults after stroke/transient ischemic attack
Arunima Kapoor, Courtney Scott, Krista L Lanctot, et al.
Journal of the American Medical Directors Association
|
February 21, 2012
Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review
Dallas P Seitz, Sarah Brisbin, Nathan Herrmann, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
July 23, 2009
Factor analysis of the Rivermead Post-Concussion Symptoms Questionnaire in mild-to-moderate traumatic brain injury patients
Nathan Herrmann, Mark J Rapoport, Ryan D Rajaram, et al.
The Journal of Clinical Psychiatry
|
September 12, 2013
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial
Paul B Rosenberg, Krista L Lanctôt, Lea T Drye, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 17, 2024
Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment
Amish Gaur, Damien Gallagher, Nathan Herrmann, et al.
International Psychogeriatrics
|
January 13, 2026
Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial
Oriel J Feldman, Nathan Herrmann, Myuri Ruthirakuhan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 11, 2017
Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies
Ka Sing P Lai, Celina S Liu, Allison Rau, et al.
Journal of Alzheimer'S Disease : JAD
|
July 20, 2019
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone
Myuri Ruthirakuhan, Nathan Herrmann, Ana C Andreazza, et al.
Brain and Behavior
|
December 5, 2017
Plasma sphingolipids and depressive symptoms in coronary artery disease
Adam Dinoff, Mahwesh Saleem, Nathan Herrmann, et al.
Page
of 47
Search research articles
Search
Showing results (271-280 of 470) with videos related to
Sort By:
Page
of 47
The Cochrane Database of Systematic Reviews
|
July 14, 2021
Mini-Cog for the detection of dementia within a community setting
Bruce A Fage, Calvin Ch Chan, Sudeep S Gill, et al.
Psychiatry Research
|
July 6, 2019
Symptoms of depression and cognitive impairment in young adults after stroke/transient ischemic attack
Arunima Kapoor, Courtney Scott, Krista L Lanctot, et al.
Journal of the American Medical Directors Association
|
February 21, 2012
Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review
Dallas P Seitz, Sarah Brisbin, Nathan Herrmann, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
July 23, 2009
Factor analysis of the Rivermead Post-Concussion Symptoms Questionnaire in mild-to-moderate traumatic brain injury patients
Nathan Herrmann, Mark J Rapoport, Ryan D Rajaram, et al.
The Journal of Clinical Psychiatry
|
September 12, 2013
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial
Paul B Rosenberg, Krista L Lanctôt, Lea T Drye, et al.
Journal of Geriatric Psychiatry and Neurology
|
May 17, 2024
Neurofilament Light Chain as a Biomarker of Global Cognition in Individuals With Possible Vascular Mild Cognitive Impairment
Amish Gaur, Damien Gallagher, Nathan Herrmann, et al.
International Psychogeriatrics
|
January 13, 2026
Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial
Oriel J Feldman, Nathan Herrmann, Myuri Ruthirakuhan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 11, 2017
Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies
Ka Sing P Lai, Celina S Liu, Allison Rau, et al.
Journal of Alzheimer'S Disease : JAD
|
July 20, 2019
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone
Myuri Ruthirakuhan, Nathan Herrmann, Ana C Andreazza, et al.
Brain and Behavior
|
December 5, 2017
Plasma sphingolipids and depressive symptoms in coronary artery disease
Adam Dinoff, Mahwesh Saleem, Nathan Herrmann, et al.
Page
of 47